Improving HIV prevention for people who inject drugs on medication for opioid use disorder
Optimizing evidence-based HIV prevention targeting people who inject drugs on PrEP
This study is looking to improve HIV prevention for people who inject drugs and are starting treatment for opioid use by helping them better understand and stick to important prevention methods, like PrEP, through fun activities that boost their thinking skills.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Storrs NIH-funded |
| Lab location | 1 site (Storrs-Mansfield, United States) |
| Project ID | NIH-10850991 on NIH RePORTER |
What this research studies
This research aims to enhance HIV prevention strategies specifically for people who inject drugs (PWID) who are starting treatment for opioid use disorder. By using a multiphase optimization strategy, the study will evaluate four key intervention components that focus on cognitive skills such as attention, memory, and information processing. The goal is to improve how these individuals understand and adhere to evidence-based HIV prevention methods, particularly Pre-Exposure Prophylaxis (PrEP). This approach acknowledges the cognitive challenges faced by many PWID, aiming to tailor interventions to better meet their needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are newly enrolled in medication for opioid use disorder.
Not a fit: Patients who do not inject drugs or are not seeking treatment for opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved adherence to HIV prevention methods among PWID, significantly reducing their risk of HIV infection.
How similar studies have performed: Previous research has shown promise in optimizing interventions for cognitive dysfunction in similar populations, indicating potential for success in this approach.
Where this research is happening
Storrs-Mansfield, United States
- University of Connecticut Storrs — Storrs-Mansfield, United States (Active)
Researchers
- Principal investigator: Copenhaver, Michael — University of Connecticut Storrs
- Study coordinator: Copenhaver, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.